1. Home
  2. ENOV vs ARI Comparison

ENOV vs ARI Comparison

Compare ENOV & ARI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENOV
  • ARI
  • Stock Information
  • Founded
  • ENOV 1995
  • ARI 2009
  • Country
  • ENOV United States
  • ARI United States
  • Employees
  • ENOV N/A
  • ARI N/A
  • Industry
  • ENOV Fluid Controls
  • ARI Real Estate Investment Trusts
  • Sector
  • ENOV Industrials
  • ARI Real Estate
  • Exchange
  • ENOV Nasdaq
  • ARI Nasdaq
  • Market Cap
  • ENOV 1.6B
  • ARI 1.5B
  • IPO Year
  • ENOV 2008
  • ARI 2009
  • Fundamental
  • Price
  • ENOV $33.19
  • ARI $10.68
  • Analyst Decision
  • ENOV Strong Buy
  • ARI Hold
  • Analyst Count
  • ENOV 6
  • ARI 4
  • Target Price
  • ENOV $51.00
  • ARI $10.08
  • AVG Volume (30 Days)
  • ENOV 970.3K
  • ARI 751.3K
  • Earning Date
  • ENOV 11-05-2025
  • ARI 10-29-2025
  • Dividend Yield
  • ENOV N/A
  • ARI 9.37%
  • EPS Growth
  • ENOV N/A
  • ARI N/A
  • EPS
  • ENOV N/A
  • ARI N/A
  • Revenue
  • ENOV $2,189,576,000.00
  • ARI $273,783,000.00
  • Revenue This Year
  • ENOV $9.13
  • ARI $26.08
  • Revenue Next Year
  • ENOV $6.39
  • ARI $18.31
  • P/E Ratio
  • ENOV N/A
  • ARI N/A
  • Revenue Growth
  • ENOV 14.40
  • ARI 55.89
  • 52 Week Low
  • ENOV $25.47
  • ARI $7.70
  • 52 Week High
  • ENOV $49.83
  • ARI $11.11
  • Technical
  • Relative Strength Index (RSI)
  • ENOV 61.78
  • ARI 55.45
  • Support Level
  • ENOV $30.44
  • ARI $10.47
  • Resistance Level
  • ENOV $33.85
  • ARI $11.11
  • Average True Range (ATR)
  • ENOV 1.06
  • ARI 0.18
  • MACD
  • ENOV 0.15
  • ARI -0.05
  • Stochastic Oscillator
  • ENOV 82.86
  • ARI 36.96

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

About ARI Apollo Commercial Real Estate Finance Inc

Apollo Commercial Real Estate Finance Inc is a real estate investment trust that primarily originates, invests in, acquires, and manages commercial first-mortgage loans, subordinate financings, commercial mortgage-backed securities, and other real estate-related debt investments. The subordinate loans and first-mortgage loans account for the vast majority of the portfolio on a cost basis. Property types include residential, retail, healthcare, office, mixed-use, hotel, industrial, multifamily, securities, and other, with residential properties and hotels representing the highest property value. More than a third of the properties are located in New York City, with the other properties located across other regions of the United States, as well as other countries.

Share on Social Networks: